Table 3.
(including only HA-VRE from clinical specimen). Results of multivariable analysis for the frequency of hospital-acquired vancomycin resistant enterococci cases with antibiotic use by antibiotic group (ATC-code 5-digit)
| Parameter/category | IRR | 95% CI | p-value |
|---|---|---|---|
| Ward | |||
| Medical ward | 1 = reference | ||
| Hematological/oncological ward | 1.38 | 0–60-3.19 | 0.451 |
| Intensive care unit | 4.7 | 2.02–10.96 | <.0001 |
| Surgical ward | 1.24 | 0.55–2.83 | 0.594 |
| Patient with community-acquired VRE on ward in the current month | 1.77 | 1.19–2.63 | 0.005 |
| Glycopetide (J01XA) use in the previous month (per 1 DDD/100 patient-days) | 1.03 | 1.01–1.05 | 0.0038 |
| Year 2015 (compared to 2014) | 1.40 | 1.05–1.86 | 0.005 |
DDD Defined daily dose; IRR Incidence rate ratio; CI Confidence interval